In high-risk PCI, maintaining patient’s hemodinamic stability is critical. The PulseCath iVAC 2L MCS device makes this possible by delivering a pulsatile flow that mimics natural physiological conditions. Its mechanical valve not only supports hemodynamic stability but also reduces the oxygen demand of the left ventricle, which is especially beneficial in complex cases. Recently, it…
PulseCath iVAC 2L LVAD device demonstrates significant potential in supporting left ventricular outflow volume during various interventional procedures. By reducing the oxygen demand on the left ventricle through the use of a mechanical valve operating in sync with cardiac cycles, the device aids in achieving hemodynamic stability in patients. This device is routinely utilized as…
Patient with multiple CTO, EF > 20%. During this high-risk PCI case with iVac-2L the patient was hemodynamically stable through the whole procedure. The iVAC 2L is a short term, fully percutaneous, 17Fr transfemoral LVAD that effectively generates blood flow up to 2 liters per minute. Congratulations to the heart team of University of Szeged.…
Protected high-risk PCI with PulseCath iVac pulsatile mechanical circulatory support at University of Szeged performed by Dr. Zoltán RUZSA. iVac 2L offers LV unloading and reduces myocardial oxygen consumption.
#PCI #protectedPCI #pVAD #MCS #coronaryintervention #PulseCath #iVac2L #DHSHungary #DeliveringHealthcareSolutions
Protected high-risk PCI with PulseCath iVac pulsatile mechanical circulatory support at University of Szeged performed by Dr. Zoltán RUZSA. iVac 2L offers LV unloading and reduces myocardial oxygen consumption particularly in patients with ACS or MR.
#PCI #protectedPCI #pVAD #MCS #coronaryintervention #PulseCath #iVac2L #DHSHungary #DeliveringHealthcareSolutions